中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2015年
4期
227-230
,共4页
药品不良反应%用药分析%合理用药
藥品不良反應%用藥分析%閤理用藥
약품불량반응%용약분석%합리용약
Adverse drug reaction%Medication analysis%Rational drug use
目的:了解我院药品不良反应的发生特点及相关因素,为临床合理用药提供参考.方法:收集我院2013-2014年上报的208例ADR报告,从患者的性别、年龄、给药途径、可疑药品种类、累及系统/器官及临床表现、ADR的转归及关联性评价等方面进行统计分析.结果:208例ADR中,男性129例(62.02%);女性79例(37.98%);发生ADR的年龄段以40 ~ 59岁最多;静脉给药所致ADR发生率最高;引发ADR的药品共涉及13类87个品种,其中以抗感染药物居多(35.10%);ADR累及系统以皮肤及其附件损害最常见,共计90例(40.18%).结论:应加强ADR报告和监测工作,加强用药监护,减少药品不良反应发生率.
目的:瞭解我院藥品不良反應的髮生特點及相關因素,為臨床閤理用藥提供參攷.方法:收集我院2013-2014年上報的208例ADR報告,從患者的性彆、年齡、給藥途徑、可疑藥品種類、纍及繫統/器官及臨床錶現、ADR的轉歸及關聯性評價等方麵進行統計分析.結果:208例ADR中,男性129例(62.02%);女性79例(37.98%);髮生ADR的年齡段以40 ~ 59歲最多;靜脈給藥所緻ADR髮生率最高;引髮ADR的藥品共涉及13類87箇品種,其中以抗感染藥物居多(35.10%);ADR纍及繫統以皮膚及其附件損害最常見,共計90例(40.18%).結論:應加彊ADR報告和鑑測工作,加彊用藥鑑護,減少藥品不良反應髮生率.
목적:료해아원약품불량반응적발생특점급상관인소,위림상합리용약제공삼고.방법:수집아원2013-2014년상보적208례ADR보고,종환자적성별、년령、급약도경、가의약품충류、루급계통/기관급림상표현、ADR적전귀급관련성평개등방면진행통계분석.결과:208례ADR중,남성129례(62.02%);녀성79례(37.98%);발생ADR적년령단이40 ~ 59세최다;정맥급약소치ADR발생솔최고;인발ADR적약품공섭급13류87개품충,기중이항감염약물거다(35.10%);ADR루급계통이피부급기부건손해최상견,공계90례(40.18%).결론:응가강ADR보고화감측공작,가강용약감호,감소약품불량반응발생솔.
Objective:To investigate the features and related factors of ADR occurred in our hospital and provide reference for rational drug use in clinic.Methods:A total of 208 ADR cases were collected from 2013 to 2014 in our hospital. The cases were analyzed statistically in respect of the age and gender distribution of the patients, administration routes, the category of the suspected drugs, organs or systems involved, clinical manifestations, outcomes and relevant evaluations of ADRs, etc.Results:Among the 208 ADR cases, 129 cases (62.02%) were male and 79 cases (37.98%) were female. Most cases were in the age of 40-59 years. The ADR incidence rate of intravenous administration was the highest. A total of 13 categories (87 kinds) of drugs were involved in ADRs, with antibacterial drugs showing the highest percentages (35.10%). There were 90 cases (40.18%) appeared as skin and its appendants damage, which were the most common clinical manifestations.Conclusion: Reporting and monitoring of ADRs as well as pharmaceutical care should be strengthened in order to reduce the occurrence of ADRs.
